Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03083080
Other study ID # 201504056
Secondary ID
Status Not yet recruiting
Phase N/A
First received February 20, 2017
Last updated March 20, 2017
Start date March 27, 2017
Est. completion date March 26, 2019

Study information

Verified date February 2017
Source Taipei Medical University WanFang Hospital
Contact Jui-An Lin
Phone +886-2-29307930
Email juian.lin@tmu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Traditionally, video-assisted thoracic surgery is performed under general anesthesia with double-lumen endotracheal tube. However, the complications associated with this large tube as well as inhalation anesthetics are frequently reported. Therefore, currently there is a trend toward non-intubated anesthesia methods for video-assisted thoracic surgery, which includes thoracic epidural block, peripheral nerve block, local anesthesia, local combined with peripheral nerve block, etc. Thoracic epidural block demands a high technique, but still risks catastrophic neurological complications in case of accidental dural puncture. Local anesthesia, perhaps more straightforward, however may need supplemental analgesia during incision, which will inevitably interrupt surgery and negatively affect the patients. This study aims to apply ultrasound guidance during local anesthetic injection for local anesthesia-based video assisted thoracic surgery, which helps inject the local anesthetic into the key intercostal nerve plane to provide more specific and precise blockade, thus avoiding the chance of blind injection. At the same time, ultrasound guidance has the potential to reduce the risk of systemic toxicity, prolong the duration of analgesia postoperatively, and facilitates postoperative recovery.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date March 26, 2019
Est. primary completion date March 26, 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years to 79 Years
Eligibility Inclusion Criteria:

- Adults younger than 80 years old and weighing between 50-90 kg are scheduled for one-port video assisted thoracic surgery .

Exclusion Criteria:

- Anticipated difficult airway

- Obvious coagulation abnormality

- Psychiatric patients or drug addiction

- Emergency operation or patients with a full stomach

- Difficulty in language expression

- Allergic to local anesthetic, morphine, or NSAID

- BMI > 35

- Pregnancy

- Respiratory insufficiency

- Severe pleural adhesion

- Need for pleurodesis

- Refuse patient-controlled analgesia

- Patients with a pacemaker

- Severe liver dysfunction (serum albumin<25g/l or Child-Pugh score?10)

- Severe kidney dysfunction (creatinine clearance<30ml/min)

- Inflammatory bowel disease

- Congestive heart failure (NYHA II-IV)

- Confirmed ischemic heart disease, peripheral arterial disease and/or cerebral vascular disease

- Patients with a high intra-ocular pressure (e.g. glaucoma)

- Neurological symptoms over the ipsilateral upper part of the body

Study Design


Related Conditions & MeSH terms

  • Efficacy and Safety of VATS Block

Intervention

Procedure:
VATS
VATS is the abbreviation of video-assisted thoracic surgery, which aims to minimize the wound for thoracic surgery and to enhance patient recovery after surgery
Drug:
Ropivacaine
30 mL 0.5% ropivacaine is used to achieve VATS block
Epinephrine
1:400000 epinephrine is mixed with ropivacaine (local anesthetic) to reduce the risk of local anesthetic systemic toxicity

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University WanFang Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Numerical rating scale intraoperatively Self-reporting pain intensity, pain site, and analgesic dosage during surgery During chest wall incision
Primary TIme to lose skin sensation (light touch and thermal) over the injection site Skin sensation will be tested every 5 minutes after ropivacaine injection until loss of both sensation (readiness for skin incision) Up to 30 mins after ropivacaine injection
Secondary Ropivacaine concentration at different time points after injection Blood sampling at seven time points (10, 20, 30, 45, 60, 90, 120 minutes following injection) Up to 120 mins following injection
Secondary Common characteristics of ultrasound anatomy by analyzing video clips Recording the ultrasound images at three time points Three time points (upon obtaining informed consent, prior to injection and during injection)
Secondary Numerical rating scale postoperatively Pain scores evaluated at six time points (at the conclusion of surgery, and at 2h, 6h, 24h, 48h, and 72h post-surgery) Up to 72 hours following surgery